Nepal

in page functions
[French]
Nepal
Total population (2017) 29,186,955
Birth cohort (2017) 578,656
Surviving Infants (surviving to 1 year per year, 2017) 563,391
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 29/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 36/1000
World Bank Index, IDA (2015) 3.39
Gross Nation Income (per capita US$, 2015) 730
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 75

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nepal

Type of support

Approvals

2001-2022 (US$)
(25 Apr 2018)

Commitments

2001-2022 (US$)
(25 Apr 2018)

Disbursements

2000-2018 (US$)
(25 Apr 2018)

% Disbursed

(25 Apr 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $135,630,552 $180,683,052 $131,465,242
Cash Support (CASHSUPP) $199,000 $224,000 $199,000 100%
Health system strengthening (HSS 1) $8,667,000 $8,667,000 $8,667,000 100%
Health system strengthening (HSS 2) $14,483,745 $14,483,745 $14,483,745 100%
Health system strengthening (HSS 3) $15,660,000 $36,540,000 $12,180,000 78%
HepB mono (NVS) $1,870,980 $1,870,980 $1,870,980 100%
HPV Demo (NVS) $303,500 $303,500 $317,257 105%
Immunisation services support (ISS) $3,312,520 $3,312,520 $3,312,520 100%
Injection Safety Devices (NVS) $390,500 $916,500 $512,964 131%
Injection safety support (INS) $1,151,893 $1,151,893 $1,151,893 100%
IPV (NVS) $3,544,749 $3,544,749 $2,867,761 81%
JEV (NVS) $1,921,000 $1,921,000 $2,149,466 112%
JEV - Operational costs (OPC) $2,374,000 $2,374,000 $2,374,000 100%
Measles (NVS) $800,702 $808,702 $671,702 84%
Penta (NVS) $37,557,014 $41,004,514 $37,690,174 100%
Pneumo (NVS) $31,390,850 $51,556,850 $31,174,317 99%
Product Switch Grant (PSG) $160,636 $160,636
Tetra DTP-HepB (NVS) $8,690,385 $8,690,385 $8,690,385 100%
Vaccine Introduction Grant (VIG) $3,152,078 $3,152,078 $3,152,078 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nepal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 87%
M:F sex ratio at birth (2017) 1.07
Household survey: DTP3 coverage for male (2013) 89.80%
Household survey: DTP3 coverage for female (2013) 86.50%
Household survey: Last DTP3 survey (2013) 88%
% districts achieving > 80% DTP3 coverage (2016) 68%
% districts achieving < 50% DTP3 coverage (2016) 1%
MCV WHO/UNICEF estimates (2016) 83%

Breakdown of support

Non-vaccine support Vaccine support
35% 65%
$45,520,236 $85,945,006

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nepal

03 April 2018

Typhoid vaccination in Nepal

New typhoid vaccine to receive Gavi support

Gavi has earmarked US$ 85 million to fund the introduction of the vaccine in the world’s poorest countries.

07 March 2018

Female vaccine heroes: two health workers, two scientists, a teacher and a town crier

If you know something about global health, you’ve probably heard of Edward Jenner or Jonas Salk, but what about the women who also helped lay the foundations for modern immunisation? Meet five remarkable women who pushed forward the frontiers of science.

11 November 2016

Feature 2 Nepal BG

Fighting pneumonia in Nepal: making numbers count

At Kathmandu’s Patan hospital, Gavi is funding impact studies on two vaccines that protect children against the main causes of deadly pneumonia: Haemophilus influenzae type b (Hib) and pneumococcal disease. Three doctors who are leading these studies identify four ways in which Patan’s pioneering research is shaping Nepal’s immunisation policy.

close icon

modal window here